These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36603970)

  • 1. Inadvertent stem cell transfer demonstrating a way for tolerance induction.
    Pilat N
    Kidney Int; 2023 Jan; 103(1):21-22. PubMed ID: 36603970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts.
    Exner BG; Acholonu IN; Bergheim M; Mueller YM; Ildstad ST
    Acta Haematol; 1999; 101(2):78-81. PubMed ID: 10202237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating cells as a venue to establish mixed chimerism and tolerance.
    Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
    Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
    Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
    Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
    Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
    PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
    Oura T; Cosimi AB; Kawai T
    Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
    Wang J; Li L; Xu M; Rong R; Zhu T
    Transplantation; 2013 Nov; 96(9):774-81. PubMed ID: 23900211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism, Transplant Tolerance, and Beyond.
    Messner F; Etra JW; Dodd-O JM; Brandacher G
    Transplantation; 2019 Aug; 103(8):1556-1567. PubMed ID: 30896678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
    Zheng HB; Watkins B; Tkachev V; Yu S; Tran D; Furlan S; Zeleski K; Singh K; Hamby K; Hotchkiss C; Lane J; Gumber S; Adams AB; Cendales L; Kirk AD; Kaur A; Blazar BR; Larsen CP; Kean LS
    Am J Transplant; 2017 Mar; 17(3):657-670. PubMed ID: 27500470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Chimerism and Organ Transplant Tolerance in Laboratory Animals: Safety and Efficacy of Adaptation to Humans.
    Lowsky R; Strober S
    Front Immunol; 2022; 13():805177. PubMed ID: 35222384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable mixed chimerism and tolerance to human organ transplants.
    Strober S
    Chimerism; 2015 Apr; 6(1-2):27-32. PubMed ID: 26855335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
    Podestà MA; Sykes M
    Front Immunol; 2021; 12():791725. PubMed ID: 35069574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.
    Ishii R; Hirai T; Miyairi S; Omoto K; Okumi M; Ishii Y; Tanabe K
    Am J Transplant; 2018 Feb; 18(2):328-340. PubMed ID: 28766890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologic malignancies in experimental and clinical studies.
    Sykes M; Spitzer TR
    Cancer Treat Res; 2002; 110():79-99. PubMed ID: 11908201
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrochimerism and clinical transplant tolerance.
    Scandling JD; Busque S; Lowsky R; Shizuru J; Shori A; Engleman E; Jensen K; Strober S
    Hum Immunol; 2018 May; 79(5):266-271. PubMed ID: 29330112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance induction: hematopoietic chimerism.
    Kawai T; Sachs DH
    Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.